| Entry |
|
|---|
| Name |
Maribavir (USAN/INN)
|
|---|
| Formula |
C15H19Cl2N3O4
|
|---|
| Exact mass |
375.0753
|
|---|
| Mol weight |
376.2351
|
|---|
| Structure |
     |
|---|
| Activity |
Treatment of cytomegalovirus infections [antiviral] [DS: H00368]
|
|---|
| Remark |
|
|---|
| Comment |
L-ribofuranosyl nucleoside
|
|---|
| Target |
DNA polymerase inhibitor [EC: 2.7.7.7] |
|---|
| Structure map |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J05 ANTIVIRALS FOR SYSTEMIC USE
J05A DIRECT ACTING ANTIVIRALS
J05AX Other antivirals
J05AX10 Maribavir
D04859 Maribavir (USAN/INN)
Antiinfectives [BR:br08307]
Antivirals
Anti-CMV agent
DNA polymerase inhibitor
Purine analogue
Maribavir [ATC:J05AX10]
D04859 Maribavir (USAN/INN)
 |
|---|
| Other DBs |
CAS: 176161-24-3 PubChem: LigandBox: NIKKAJI: |
|---|
| KCF data |
ATOM 24
1 C1y C 43.1900 -28.0000
2 C1y C 44.5900 -28.0000
3 C1y C 45.0226 -26.6685
4 O2x O 43.8900 -25.8456
5 C1y C 42.7574 -26.6685
6 O1a O 42.3671 -29.1326
7 O1a O 45.4129 -29.1326
8 C1b C 46.3422 -26.2397
9 O1a O 47.3865 -27.1799
10 C8y C 38.2900 -23.0300
11 C8y C 38.2900 -24.4300
12 C8x C 39.4800 -25.1300
13 C8y C 40.7400 -24.4300
14 C8y C 40.7400 -23.0300
15 C8x C 39.4800 -22.3300
16 N4y N 42.0700 -24.8500
17 C8y C 42.8400 -23.7300
18 N5x N 42.0700 -22.6100
19 N1b N 44.2400 -23.7300
20 C1c C 44.9400 -22.5400
21 C1a C 46.3400 -22.5400
22 C1a C 44.2400 -21.3500
23 X Cl 37.0300 -25.1300
24 X Cl 37.0300 -22.3300
BOND 26
1 1 2 1
2 2 3 1
3 3 4 1
4 4 5 1
5 1 5 1
6 1 6 1 #Down
7 2 7 1 #Down
8 3 8 1 #Up
9 8 9 1
10 10 11 2
11 11 12 1
12 12 13 2
13 13 14 1
14 14 15 2
15 10 15 1
16 13 16 1
17 16 17 1
18 17 18 2
19 14 18 1
20 17 19 1
21 19 20 1
22 20 21 1
23 20 22 1
24 11 23 1
25 10 24 1
26 5 16 1 #Up
|
|---|
